Correlation Between Mereo BioPharma and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and DiaMedica Therapeutics, you can compare the effects of market volatilities on Mereo BioPharma and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and DiaMedica Therapeutics.
Diversification Opportunities for Mereo BioPharma and DiaMedica Therapeutics
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mereo and DiaMedica is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Mereo BioPharma and DiaMedica Therapeutics
Given the investment horizon of 90 days Mereo BioPharma Group is expected to generate 1.01 times more return on investment than DiaMedica Therapeutics. However, Mereo BioPharma is 1.01 times more volatile than DiaMedica Therapeutics. It trades about 0.1 of its potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.04 per unit of risk. If you would invest 124.00 in Mereo BioPharma Group on September 12, 2024 and sell it today you would earn a total of 262.00 from holding Mereo BioPharma Group or generate 211.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mereo BioPharma Group vs. DiaMedica Therapeutics
Performance |
| Timeline |
| Mereo BioPharma Group |
| DiaMedica Therapeutics |
Mereo BioPharma and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mereo BioPharma and DiaMedica Therapeutics
The main advantage of trading using opposite Mereo BioPharma and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |